Pre-restart assessment should include: Review of the reason for discontinuation and whether it has been adequately addressed Current weight and glycemic status (if diabetic) Assessment of gastrointestinal symptoms and any contraindications Medication reconciliation to identify potential drug interactions For patients taking insulin or sulfonylureas, consider dose reductions to prevent hypoglycemia For women of childbearing potential using oral contraceptives, recommend backup contraception for 4 weeks after restarting and after each dose increase Discussion of realistic expectations and commitment to continued treatment Patient counseling is essential

Experts advice on how to maintain weight loss after stopping Mounjaro and Ozempic jabs People who lose weight using injections can put the weight back on four times faster than traditional dieters Bookmark CommentsGo to comments Weight-loss drugs such as Mounjaro have been praised for triggering dramatic weight loss for about 1.6 million people in the UK
Not knowing what really lay ahead after the procedure, Dr
The new Huberman Lab episode is out: Your Top Health Questions Answered 0:00 Your Questions Answered 1:42 Late-Day Training & Pre-Workout, Cortisol
Patients often report initial gastrointestinal side effects, such as nausea and vomiting, which can be distressing and sometimes lead to discontinuation of the drug
In an early randomized clinical trial, low-dose semaglutide reduced how much people drank in a lab setting and lowered their weekly alcohol cravings compared with a placebo